Antiseptic resistance in bacteria could lead to next-gen plastics
Ancient protein pumps could be key to new green polymers
The molecular machinery used by bacteria to resist chemicals designed to kill them could also help produce precursors for a new generation of nylon and other polymers, according to new research by scientists from Australia and the UK.

This is a highly magnified cluster of Acinetobacter baumannii bacteria, which uses a protein pump to resist the powerful hospital-grade antiseptic, chlorhexidine.
Janice Haney Carr (Public Health Image Library)
"Resistance to artificial antiseptics appears to be a lucky accident for the bacteria, and it could also be useful for humans," says Professor Ian Paulsen of Australia's Macquarie University, one of the leaders of the research group.
Bacteria that are unaffected by antiseptics and antibiotics, often termed "superbugs", are a growing problem, but exactly how they develop resistance is not fully understood.
In 2013 Paulsen and colleagues discovered how a bacterium called Acinetobacter baumannii resisted chlorhexidine, a powerful hospital-grade antiseptic listed by the World Health Organisation as an "essential medicine".
A. baumannii's secret weapon, they found, is a protein called AceI, which sits on its surface and pumps out any chlorhexidine that gets inside. That was surprising, because the protein has been around for a lot longer than the antiseptic.
"The gene that encodes the AceI protein appears to be very old, but chlorhexidine was only created in the twentieth century," says lead author Dr Karl Hassan, from Australia's University of Newcastle.
"So the gene can't have the native function of protecting against chlorhexidine. It's a side reaction that is fortunate for the bacteria."
Now Hassan, Paulsen and colleagues have looked at what other compounds are transported by AceI and its relations, collectively known as Proteobacterial Antimicrobial Compound Efflux (PACE) proteins.
They found good news and bad news. The bad news was that PACE proteins are likely to be future engines of antimicrobial resistance. The good news is that their ability to transport a wide range of substances means that they could be effectively repurposed in an industrial context to catalyse the manufacture of "petroleum-free" polymers such as nylon.
"These PACE proteins are very promiscuous in the compounds that they transport and are a likely cause of future resistance to new antimicrobials that are currently being developed," says Professor Peter Henderson at the University of Leeds, a senior researcher on the team.
Original publication
Hassan, KA, Naidu, V, Edgerton, JR, Mettrick, KA, Liu, Q, Fahmy, L, Li, L, Jackson, SM, Ahmad, I, Sharples, D, Henderson, PJF, Paulsen, IT ; Proceedings of the National Academy of Sciences; 2019
Most read news
Original publication
Hassan, KA, Naidu, V, Edgerton, JR, Mettrick, KA, Liu, Q, Fahmy, L, Li, L, Jackson, SM, Ahmad, I, Sharples, D, Henderson, PJF, Paulsen, IT ; Proceedings of the National Academy of Sciences; 2019
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics

Artificial intelligence, hardware innovations boost confocal microscope’s performance - Enhancing the workhorse
Anemia: Baffling lab mystery leads to major red blood cell discovery
BioPhausia focuses and sells OTC products to Meda for SEK 190 million
The Biotechnology Industry over 30 Billion in Revenue - ASEBIO presented its annual report "Informe ASEBIO 2009"

Vitamin B6 may help keep COVID-19's cytokine storms at bay - Vitamin B6 may help calm cytokine storms and unclog blood clots linked to COVID-19's lethality

Born to break - Mutation causes fragile bones

"Dormant" magnetosome genes in non-magnetic bacteria discovered

How injured nerves stop themselves from healing - Researchers have discovered an unexpected effect: It might open up new avenues for developing therapies after brain or spinal cord damage
Scil Proteins Signs Research Collaboration with the Martin Luther University Halle-Wittenberg for Gastrointestinal Tumors
Cotton fibres instead of carbon nanotubes
